Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by Nathalie Bonnefoy
Group name EquipeNB
Item Type Journal Article
Title [Radiosensitivity settings in breast cancer]
Creator Lauche et al.
Author O. Lauche
Author D. Azria
Author O. Riou
Author M. Charissoux
Author C. Lemanski
Author C. Bourgier
Abstract Breast cancers are highly radiosensitive since the risk of recurrences and of mortality after adjuvant radiotherapy following breast-conserving surgery is decreased by 15.7% and 3.8%, respectively at 10 years. The total dose if irradiation also significantly increases local control: a boost of 16 Gy to the tumour bed after breast-conserving surgery reduces the absolute risk of recurrence by 4% at 10 years. Breast cancers are sensitive to the dose per fraction, as shown by the results from four randomized trials which compared standard irradiation (50 Gy/25 fractions) with a hypofractionated scheme: no statistical difference was observed in locoregional recurrence and overall survival at 10 years. The ?/? ratio, which reflects the dose per fraction and is theoretically over 10 Gy for tumour tissues, has been estimated between 2.2 and 4.4 Gy for breast cancers. Molecular abnormalities, such as overexpression of HER1 (especially in triple negative breast cancer) and HER2, induce a higher radioresistance. In vitro studies showed that targeted therapies, which block these receptors, increase breast cancer radiosensitivity. Tumour stem cells have been identified in breast cancers and are characterized by a higher radioresistance. This radioresistance could be related to a better repair of radiation-induced DNA damages and a decrease of reactive oxygen species (ROS), which are involved in their occurrence. In the future, a better understanding of genetics tumour abnormalities will allow to identify new radiosensitivity settings in breast cancers.
Publication Cancer Radiotherapie: Journal De La Societe Francaise De Radiotherapie Oncologique
Volume 19
Issue 4
Pages 237-240
Date Jun 2015
Journal Abbr Cancer Radiother
Language fre
DOI 10.1016/j.canrad.2015.04.001
ISSN 1769-6658
Library Catalog PubMed
Extra PMID: 26006764
Tags Breast Neoplasms, Cancer du sein, Cellules souches tumorales, Dose-Response Relationship, Radiation, Female, Humans, Hypofractionated and cancer stem cells, Hypofractionnement, Radiosensibilité, Radiosensitivity, review
Date Added 2019/05/28 - 21:48:08
Date Modified 2019/05/28 - 21:48:19
Notes and Attachments PubMed entry (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés